Table 2.
Patient disease characteristics and medications
| n, % | |
|---|---|
| Disease Characteristics | |
| NYHA class II | 12, 75 |
| NYHA class III | 4, 25 |
| NYHA class IV | 0, 0 |
| Diabetes | 3, 19 |
| COPD | 2, 13 |
| CAD | 4, 25 |
| Hypertension | 9, 56 |
| Hyperlipidemia | 7, 44 |
| Medications | |
| β-Blockers | 7, 44 |
| ACEi | 3, 19 |
| ARB | 5, 31 |
| Loop diuretics | 12, 75 |
| Aldosterone antagonists | 12, 75 |
| Statin | 9, 56 |
| Nitrates | 2, 13 |
| Ca2+ channel blocker | 6, 38 |
| Mean Rx types taken, n | 3.5 ± 1.4 |
Patients taking prescription (Rx), % 100 ACEi, angiotensin-converting-enzyme inhibitor; ARB, angiotensin II receptor blocker; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; NYHA class, New York Heart Association functional classification.